Retrogen utilizes one of the industry’s top-rated platforms for Next Generation Sequencing (NGS), enabling massively parallel sequencing for almost any molecular genetics application. The flexible and scalable nature of the technology allows investigators to interrogate genomes, exomes, transcriptomes, or even just thousands of PCR amplicons in parallel, leading to significant data sets and decreased time to a conclusion. With the ability to multiplex using sample indices, your throughput will reach new speeds.
Retrogen uses Illumina’s sequencing by synthesis chemistry – compatible with the MiSeq and enabling small genome de novo or resequencing, SNP profiling, targeted enrichment, and amplicon sequencing. Additionally, Retrogen’s NGS offers workflows that support clinical diagnostics, prenatal testing, and women’s health, all available under a CLIA/CAP-regulated environment. Contact a sales representative today to bring your research into the next generation.
Types of Service
De Novo Sequencing
Cancer Hotspot Panel v2
Childhood Cancer Panel
Comprehensive Cancer Panel
|xGen Lockdown Panels (IDT)
Inherited Disease Panel
|KAPA HyperPrep Kits for Library Construction
gDNA, mtDNA, and cDNA-derived Amplicons
Vector/Plasmid Insert Sequencing
High-Sample Volume Genotyping
Metagenomics (16S rRNA)
Features & Benefits
Data routinely above Q30.
Quick Turnaround time
Design -> Review -> Confirm -> Order -> Sample QC -> Library Construction -> Sequencing QC -> Sequencing -> Data Analysis